Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D V Cramer

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
Transplantation|September 1, 1990
Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hostsL Makowka, F A Chapman, D V Cramer, et al.
Transplantation Proceedings|February 1, 1993
Effects of brequinar sodium on cynomolgus monkeys: immunosuppression and pharmacokineticsB D Jaffee, E A Jones, I Zajac, et al.
Transplantation Proceedings|June 24, 1998
Genetic characteristics of anti-donor immunoglobulin G antibodies in the hamster-to-rat model of xenotransplantationE Gochi, D V Cramer, G D Wu, et al.
Transplantation|June 1, 1993
Removal of natural human xenoantibodies to pig vascular endothelium by perfusion of blood through pig kidneys and liversP J Tuso, D V Cramer, C Yasunaga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
The human antibody response to porcine xenoantigens is encoded by IGHV3-11 and IGHV3-74 IgVH germline progenitorsM Kearns-Jonker, J Swensson, C Ghiuzeli, et al.
Transplantation Proceedings|April 1, 1992
A comparison of lymphocytic subsets participating in concordant cardiac xenograft and acute cardiac allograft rejectionD V Cramer, G D Wu, F A Chapman, et al.
Transplantation|October 1, 1992
Prevention of liver allograft rejection in rats by a short course of therapy with Brequinar SodiumD V Cramer, M Knoop, F A Chapman, et al.
Transplantation Proceedings|June 1, 1993
Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejectionC A Cosenza, D V Cramer, G Eiras-Hreha, et al.
Human Immunology|February 1, 1986
Genetics of the antibody response to an endothelial transplantation antigen in the ratJ J Blankert, L A van Es, H W Kunz, et al.
Transplantation|August 1, 1990
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapyN Murase, D G Kim, S Todo, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Transplantation|September 1, 1990
Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hostsL Makowka, F A Chapman, D V Cramer, et al.
Transplantation Proceedings|February 1, 1993
Effects of brequinar sodium on cynomolgus monkeys: immunosuppression and pharmacokineticsB D Jaffee, E A Jones, I Zajac, et al.
Transplantation Proceedings|June 24, 1998
Genetic characteristics of anti-donor immunoglobulin G antibodies in the hamster-to-rat model of xenotransplantationE Gochi, D V Cramer, G D Wu, et al.
Transplantation|June 1, 1993
Removal of natural human xenoantibodies to pig vascular endothelium by perfusion of blood through pig kidneys and liversP J Tuso, D V Cramer, C Yasunaga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
The human antibody response to porcine xenoantigens is encoded by IGHV3-11 and IGHV3-74 IgVH germline progenitorsM Kearns-Jonker, J Swensson, C Ghiuzeli, et al.
Transplantation Proceedings|April 1, 1992
A comparison of lymphocytic subsets participating in concordant cardiac xenograft and acute cardiac allograft rejectionD V Cramer, G D Wu, F A Chapman, et al.
Transplantation|October 1, 1992
Prevention of liver allograft rejection in rats by a short course of therapy with Brequinar SodiumD V Cramer, M Knoop, F A Chapman, et al.
Transplantation Proceedings|June 1, 1993
Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejectionC A Cosenza, D V Cramer, G Eiras-Hreha, et al.
Human Immunology|February 1, 1986
Genetics of the antibody response to an endothelial transplantation antigen in the ratJ J Blankert, L A van Es, H W Kunz, et al.
Transplantation|August 1, 1990
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapyN Murase, D G Kim, S Todo, et al.
Pageof 18